Turning fruit fly immune discoveries into new anti-inflammatory treatments
From Drosophila Immunity to Anti-Inflammatories
This project uses findings from fruit fly immunity to create new anti-inflammatory treatments for people with infections or autoimmune diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-11225128 on NIH RePORTER |
What this research studies
Researchers study how fruit flies detect microbes and trigger fast immune responses that can sometimes become harmful. They map the receptors and signaling steps that drive inflammation in flies and test molecules that might block or calm those signals. Because many innate immune pathways are similar in humans, the lab findings can point to targets for new medicines. The current work is laboratory-based rather than enrolling patients.
Who could benefit from this research
Good fit: People with autoimmune diseases or recurrent inflammatory problems from bacterial infections would be the most likely candidates for future trials informed by this research.
Not a fit: Patients with conditions unrelated to innate immune overactivity or those needing immediate clinical interventions are unlikely to benefit directly from this basic lab research.
Why it matters
Potential benefit: If successful, the work could identify drug targets or lead to therapies that reduce harmful inflammation in infectious and autoimmune conditions.
How similar studies have performed: Work in fruit flies has already led to major discoveries like Toll receptors and NF-κB that transformed immunology, though turning those findings into new anti-inflammatory drugs is still progressing.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Silverman, Neal — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Silverman, Neal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.